Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and Tolerability of AP701
NCT04708795Phase 1Completed
- Start
- Jan 2020
- Primary completion
- Mar 2021
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of AP701. Primary endpoints: Evaluation of pharmacokinetic parameter of THC (area under the curve) at 30 hours, Evaluation of pharmacokinetic parameter of THC (maximum observed drug concentration) at 30 hours and 14 more. Started Jan 2020; status: completed.
02
Drugs
AP701
Beyond the preview
Go deeper on NCT04708795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04708795.